Opendata, web and dolomites

MedicalPhant SIGNED

An advanced 3D simulator to generate 3D-personalized tissue and organ models for diagnosis, planning and pre-treatment of medical vascular interventions

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MedicalPhant project word cloud

Explore the words cloud of the MedicalPhant project. It provides you a very rough idea of what is the project "MedicalPhant" about.

innovative    pathology    3m    trials    industrial    simulating    surgery    opinion    certification    charge    simulator    environment    replicate    planning    acute    clinical    mechanical    vasculature    provides    cash    eco    private    initial    errors    prototype    diagnostic    plan    roi    personalized    cardiovascular    identical    mri    treatment    external    situations    organ    trl6    diagnosis    public    valida    commercialized    projected    mark    ce    patient    plus    licensing    business    medical    amount    validated    capacity    certificating    universities    associations    diseases    printing       safety    cumulative    stakeholders    innovation    physical    hospitals    penetration    3d    combination    internal    intervention    commercialize    death    leaders    ones    obtain    estimation    device    improves    specialized    interventions    models    patients    market    emerged    globally    medicalphant    consists    model    cat    flow    company    fda    carry   

Project "MedicalPhant" data sheet

The following table provides information about the project.

Coordinator
VALIDA INNOVATION SOCIEDAD LIMITADA 

Organization address
address: CALLE HERNAN CORTES, NUM 24 PLANTA 1 PUERTA 1
city: VALENCIA
postcode: 46004
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website https://www.validainnovation.com/medicalphant/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VALIDA INNOVATION SOCIEDAD LIMITADA ES (VALENCIA) coordinator 50˙000.00

Map

 Project objective

VALIDA INNOVATION S.L. emerged with the goal of developing a new 3D simulator that improves the diagnosis, planning and pre-treatment interventions and therefore, improving patient safety and reduction of associated cost to medical errors. This simulator provides a high value in 3D organ models due to its physical mechanical identical to the real ones are able to replicate the patient´s own organ and pathology. The main objective of MedicalPhant project is to develop and commercialized, based on MRI, ECO and CAT studies on patients, a cardiovascular personalized model of external and internal vasculature that allows simulating complex clinical situations due to cardiovascular diseases are the main cause of death globally. Currently, the simulator prototype has a technology level TRL6 and it has been validated in a relevant environment through its implementation in a real case study of cardiovascular surgery providing diagnostic capacity before intervention and patient´s safety after intervention. However, the company needs to work in the implementation of the business model, in the industrial adaptation of our prototype and, in achieving the certification of our 3D simulator to be commercialized. The key stakeholders involved in this project will be hospitals to carry out clinical trials, private, public hospitals and universities to use our technology, specialized organizations in charge of certificating our device to obtain the CE Mark and FDA, key opinion leaders to get a better penetration on the market and patient associations which will contribute to the dissemination of our innovative 3D printing technology in the cardiovascular market. The initial plan to commercialize the MedicalPhant consists in the combination of own production with a partner plus licensing of the technology. According to our estimation, the cumulative cash flow projected by VALIDA INNOVATION at year 5 will amount €10.3M meaning a ROI of 2.6%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDICALPHANT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDICALPHANT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MealHero (2019)

Automated cooking for tasty and healthy meals in a convenient way

Read More  

MindTrack (2019)

Analysis of eye vergence responses for the early detection and monitoring of cognitive and mental disorders

Read More  

BEMYEYES (2019)

Specialized Help from Be My Eyes – harnessing technology to connect companies directly with their blind and visually impaired users

Read More